Johnson & Johnson Vision,† announced on September 28, 2022, that Food and Drug Administration (FDA) approval of an expanded range of ACUVUE® Abiliti™ Overnight Therapeutic...
As a -12.00D myope, Chandra Mickles, OD, MS, FAAO, FSLS, Johnson & Johnson Vision North America professional education lead, myopia, understands that myopia “is...
A recent WO Poll asked readers whether they feel a name change is necessary or desirable as life circumstances change.
Thirty-five percent of respondents reported...
Have you been a victim of optical loss or theft? Is it possible to prevent? Email us at mbijlefeld@jobson.com.
Loading…
To view other WO polls and results,...
